Keith Philibert

468 total citations
9 papers, 362 citations indexed

About

Keith Philibert is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Keith Philibert has authored 9 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Physiology. Recurrent topics in Keith Philibert's work include Alzheimer's disease research and treatments (3 papers), Peptidase Inhibition and Analysis (2 papers) and Cellular transport and secretion (2 papers). Keith Philibert is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Peptidase Inhibition and Analysis (2 papers) and Cellular transport and secretion (2 papers). Keith Philibert collaborates with scholars based in United States, Canada and Germany. Keith Philibert's co-authors include Marc Glucksman, Yifan Fu, Nicholas M. Kanaan, Sarah M. Brooker, Sarah Ward, Laurel Vana, Christine Remmers, Juan F. Reyes, Lester I. Binder and Kristina R. Patterson and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Endocrinology.

In The Last Decade

Keith Philibert

9 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith Philibert United States	6	270	149	114	72	66	9	362
Diana S. Himmelstein United States	6	266 1.0×	169 1.1×	89 0.8×	90 1.3×	59 0.9×	6	374
Anat Boehm‐Cagan Israel	8	288 1.1×	155 1.0×	105 0.9×	76 1.1×	74 1.1×	11	421
Kristina Sennvik Sweden	7	278 1.0×	162 1.1×	86 0.8×	62 0.9×	51 0.8×	8	374
Sophie Robinson United Kingdom	7	180 0.7×	196 1.3×	111 1.0×	52 0.7×	77 1.2×	8	433
Natasha Deters Australia	7	215 0.8×	135 0.9×	97 0.9×	60 0.8×	52 0.8×	7	352
Celia Fernandez United States	7	228 0.8×	238 1.6×	125 1.1×	42 0.6×	98 1.5×	7	482
Roula Papadopoulos Australia	6	323 1.2×	216 1.4×	165 1.4×	69 1.0×	41 0.6×	8	455
Arames Crameri Switzerland	6	216 0.8×	219 1.5×	78 0.7×	45 0.6×	36 0.5×	6	428
Caroline Kerridge United Kingdom	5	239 0.9×	164 1.1×	69 0.6×	39 0.5×	82 1.2×	5	339
Hanjun Guan United States	9	227 0.8×	150 1.0×	129 1.1×	63 0.9×	46 0.7×	12	407

Countries citing papers authored by Keith Philibert

Since Specialization

Citations

This map shows the geographic impact of Keith Philibert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Philibert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Philibert more than expected).

Fields of papers citing papers by Keith Philibert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Philibert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Philibert. The network helps show where Keith Philibert may publish in the future.

Co-authorship network of co-authors of Keith Philibert

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Philibert. A scholar is included among the top collaborators of Keith Philibert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Philibert. Keith Philibert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Glucksman, Marc, et al.. (2017). ′Ome is where the Wound is: Biomarkers of Healing in Chronic Diabetic Foot Ulcers. The FASEB Journal. 31(S1). 1 indexed citations

2.

Woitowich, Nicole C., et al.. (2015). EP24.15 as a Potential Regulator of Kisspeptin Within the Neuroendocrine Hypothalamus. Endocrinology. 157(2). 820–830. 4 indexed citations

3.

Philibert, Keith, Robert A. Marr, Eric M. Norstrom, & Marc Glucksman. (2014). Identification and characterization of AÎ² peptide interactors in Alzheimerâ€™s disease by structural approaches. Frontiers in Aging Neuroscience. 6. 265–265. 10 indexed citations

4.

Camacho‐Vanegas, Olga, Sandra Catalina Camacho, Jacob E. Till, et al.. (2012). Primate Genome Gain and Loss: A Bone Dysplasia, Muscular Dystrophy, and Bone Cancer Syndrome Resulting from Mutated Retroviral-Derived MTAP Transcripts. The American Journal of Human Genetics. 90(4). 614–627. 23 indexed citations

5.

Patterson, Kristina R., Christine Remmers, Yifan Fu, et al.. (2011). Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease. Journal of Biological Chemistry. 286(26). 23063–23076. 279 indexed citations

6.

Huang, Jiayi, et al.. (2008). Human membrane metallo-endopeptidase-like protein degrades both beta-amyloid 42 and beta-amyloid 40. Neuroscience. 155(1). 258–262. 22 indexed citations

7.

Swanson, Todd A., et al.. (2004). The Role of Neuropeptide Processing Enzymes in Endocrine (Prostate) Cancer: EC 3.4.24.15 (EP24.15). Protein and Peptide Letters. 11(5). 471–478. 13 indexed citations

8.

Zwiers, H., et al.. (1997). Endogenous ADP-Ribosylation of Phosphoprotein B-50/GAP-43 and other Neuronal Substrates. Advances in experimental medicine and biology. 419. 279–288. 2 indexed citations

9.

Philibert, Keith & Henk Zwiers. (1995). Evidence for multisite ADP-ribosylation of neuronal phosphoprotein B-50/GAP-43. Molecular and Cellular Biochemistry. 149-150(1). 183–190. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact